{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:24Z","timestamp":1772119764620,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11033-021-06616-2","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T05:55:11Z","timestamp":1628574911000},"page":"6085-6091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer"],"prefix":"10.1007","volume":"48","author":[{"given":"Nur Selvi","family":"Gunel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihal","family":"Birden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cansu Caliskan","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bakiye Goker","family":"Bagca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrouz","family":"Shademan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Sogutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan Pinar","family":"Ozates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-3124","authenticated-orcid":false,"given":"Cigir Biray","family":"Avci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"issue":"4","key":"6616_CR1","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1530\/ERC-15-0555","volume":"23","author":"D Viola","year":"2016","unstructured":"Viola D et al (2016) Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocr Relat Cancer 23(4):R185\u2013R205. https:\/\/doi.org\/10.1530\/ERC-15-0555","journal-title":"Endocr Relat Cancer"},{"key":"6616_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fendo.2017.00312","volume":"8","author":"D Tumino","year":"2017","unstructured":"Tumino D et al (2017) Updates on the management of advanced, metastatic, and radioiodine refractory differentiated thyroid cancer. Front Endocrinol 8:312. https:\/\/doi.org\/10.3389\/fendo.2017.00312","journal-title":"Front Endocrinol"},{"issue":"10","key":"6616_CR3","doi-asserted-by":"publisher","first-page":"e22547","DOI":"10.1002\/jbt.22547","volume":"34","author":"N Ozdemir Kutbay","year":"2020","unstructured":"Ozdemir Kutbay N et al (2020) Effects of metformin and pioglitazone combination on apoptosis and AMPK\/mTOR signaling pathway in human anaplastic thyroid cancer cells. J Biochem Mol Toxicol 34(10):e22547. https:\/\/doi.org\/10.1002\/jbt.22547","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"6616_CR4","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3892\/etm.2019.7864","volume":"18","author":"JW Bi","year":"2019","unstructured":"Bi JW et al (2019) MiR-599 serves a suppressive role in anaplastic thyroid cancer by activating the T-cell intracellular antigen. Exp Ther Med 18(4):2413\u20132420. https:\/\/doi.org\/10.3892\/etm.2019.7864","journal-title":"Exp Ther Med"},{"issue":"1","key":"6616_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-88617-6","volume":"11","author":"S Pirr\u00f2","year":"2021","unstructured":"Pirr\u00f2 S et al (2021) The microRNA analysis portal is a next-generation tool for exploring and analyzing miRNA-focused data in the literature. Sci Rep 11(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-021-88617-6","journal-title":"Sci Rep"},{"issue":"1","key":"6616_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4331\/wjbc.v8.i1.45","volume":"8","author":"S Oliveto","year":"2017","unstructured":"Oliveto S et al (2017) Role of microRNAs in translation regulation and cancer. World J Biol Chem 8(1):45. https:\/\/doi.org\/10.4331\/wjbc.v8.i1.45","journal-title":"World J Biol Chem"},{"issue":"3","key":"6616_CR7","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1530\/EJE-15-0647","volume":"174","author":"A W\u00f3jcicka","year":"2016","unstructured":"W\u00f3jcicka A et al (2016) Mechanisms in endocrinology: microRNA in diagnostics and therapy of thyroid cancer. Eur J Endocrinol 174(3):R89\u2013R98. https:\/\/doi.org\/10.1530\/EJE-15-0647","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"6616_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15386\/cjmed-512","volume":"89","author":"V Pileczki","year":"2016","unstructured":"Pileczki V et al (2016) MicroRNAs as regulators of apoptosis mechanisms in cancer. Clujul Med 89(1):50. https:\/\/doi.org\/10.15386\/cjmed-512","journal-title":"Clujul Med"},{"issue":"1","key":"6616_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-21935-4","volume":"8","author":"KD Alotaibi","year":"2018","unstructured":"Alotaibi KD et al (2018) Phosphorus speciation in a prairie soil amended with MBM and DDG ash: sequential chemical extraction and synchrotron-based XANES spectroscopy investigations. Sci Rep 8(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-018-21935-4","journal-title":"Sci Rep"},{"issue":"13","key":"6616_CR10","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.3390\/cancers13133372","volume":"13","author":"V De Paolis","year":"2021","unstructured":"De Paolis V et al (2021) Epitranscriptomics: a new layer of microRNA regulation in cancer. Cancers 13(13):3372. https:\/\/doi.org\/10.3390\/cancers13133372","journal-title":"Cancers"},{"issue":"4","key":"6616_CR11","first-page":"161","volume":"2","author":"A Ardekani","year":"2010","unstructured":"Ardekani A, Naeini MM (2010) The role of microRNAs in human diseases. Avicenna J Med Biotechnol 2(4):161","journal-title":"Avicenna J Med Biotechnol"},{"issue":"10","key":"6616_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/10245332.2016.1193962","volume":"21","author":"X Kuang","year":"2016","unstructured":"Kuang X et al (2016) Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes. J Hematol 21(10):593\u2013602. https:\/\/doi.org\/10.1080\/10245332.2016.1193962","journal-title":"J Hematol"},{"issue":"3","key":"6616_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3803\/EnM.2017.32.3.326","volume":"32","author":"X Zhu","year":"2017","unstructured":"Zhu X, Cheng SY (2017) Epigenetic modifications: novel therapeutic approach for thyroid cancer. Endocrinol Metab 32(3):326","journal-title":"Endocrinol Metab"},{"issue":"10","key":"6616_CR14","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1093\/nar\/gkz292","volume":"47","author":"R Rahhal","year":"2019","unstructured":"Rahhal R, Seto E (2019) Emerging roles of histone modifications and HDACs in RNA splicing. Nucleic Acids Res 47(10):4911\u20134926. https:\/\/doi.org\/10.1093\/nar\/gkz292","journal-title":"Nucleic Acids Res"},{"key":"6616_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pharmthera.2014.11.003","volume":"147","author":"A Abend","year":"2015","unstructured":"Abend A, Kehat I (2015) Histone deacetylases as therapeutic targets\u2014from cancer to cardiac disease. Pharmacol Ther 147:55\u201362. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.003","journal-title":"Pharmacol Ther"},{"issue":"15","key":"6616_CR16","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.yexcr.2012.04.018","volume":"318","author":"P Di Fazio","year":"2012","unstructured":"Di Fazio P et al (2012) Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines. Exp Cell Res 318(15):1832\u20131843. https:\/\/doi.org\/10.1016\/j.yexcr.2012.04.018","journal-title":"Exp Cell Res"},{"issue":"4","key":"6616_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/cancers13040634","volume":"13","author":"R Jenke","year":"2021","unstructured":"Jenke R et al (2021) Anticancer therapy with HDAC inhibitors: mechanism-based combination strategies and future perspectives. Cancers 13(4):634. https:\/\/doi.org\/10.3390\/cancers13040634","journal-title":"Cancers"},{"issue":"1","key":"6616_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1124\/pr.111.005512","volume":"65","author":"CT Chiu","year":"2013","unstructured":"Chiu CT et al (2013) Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev 65(1):105\u2013142. https:\/\/doi.org\/10.1124\/pr.111.005512","journal-title":"Pharmacol Rev"},{"key":"6616_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-020-00304-2","author":"Y Sixto-L\u00f3pez","year":"2020","unstructured":"Sixto-L\u00f3pez Y et al (2020) Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach. J Comput Aided Mol Des. https:\/\/doi.org\/10.1007\/s10822-020-00304-2","journal-title":"J Comput Aided Mol Des"},{"key":"6616_CR20","doi-asserted-by":"publisher","DOI":"10.31768\/2312-8852.2018.40(2):95-100","author":"M Sanaei","year":"2018","unstructured":"Sanaei M et al (2018) Effect of valproic acid in comparison with vorinostat on cell growth inhibition and apoptosis induction in the human colon cancer SW48 cells in vitro. Exp Oncol. https:\/\/doi.org\/10.31768\/2312-8852.2018.40(2):95-100","journal-title":"Exp Oncol"},{"issue":"5","key":"6616_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3325\/cmj.2017.58.349","volume":"58","author":"XJ Ma","year":"2017","unstructured":"Ma XJ et al (2017) The role and possible molecular mechanism of valproic acid in the growth of MCF-7 breast cancer cells. Croat Med J 58(5):349\u2013357. https:\/\/doi.org\/10.3325\/cmj.2017.58.349","journal-title":"Croat Med J"},{"issue":"7","key":"6616_CR22","doi-asserted-by":"publisher","first-page":"R415","DOI":"10.1530\/ERC-19-0093","volume":"26","author":"C Zafon","year":"2019","unstructured":"Zafon C et al (2019) DNA methylation in thyroid cancer. Endocr Relat Cancer 26(7):R415\u2013R439","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"6616_CR23","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3892\/ol.2017.5593","volume":"13","author":"F Wang","year":"2017","unstructured":"Wang F et al (2017) Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer. Oncol Lett 13(3):1048\u20131057. https:\/\/doi.org\/10.3892\/ol.2017.5593","journal-title":"Oncol Lett"},{"issue":"15","key":"6616_CR24","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.1158\/0008-5472","volume":"66","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM (2006) MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66(15):7390\u20137394. https:\/\/doi.org\/10.1158\/0008-5472","journal-title":"Cancer Res"},{"issue":"5","key":"6616_CR25","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3892\/ijmm.2019.4328","volume":"44","author":"L Zhu","year":"2019","unstructured":"Zhu L et al (2019) miR-217 inhibits the migration and invasion of HeLa cells through modulating MAPK1. Int J Mol Med 44(5):1824\u20131832. https:\/\/doi.org\/10.3892\/ijmm.2019.4328","journal-title":"Int J Mol Med"},{"issue":"18","key":"6616_CR26","first-page":"4050","volume":"21","author":"J Yang","year":"2017","unstructured":"Yang J et al (2017) MicroRNA-217 functions as a prognosis predictor and inhibits pancreatic cancer cell proliferation and invasion via targeting E2F3. Eur Rev Med Pharmacol Sci 21(18):4050\u20134057","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"6616_CR27","first-page":"1759","volume":"21","author":"YP Liu","year":"2017","unstructured":"Liu YP et al (2017) MicroRNA-217 suppressed epithelial-to-mesenchymal transition in gastric cancer metastasis through targeting PTPN14. Eur Rev Med Pharmacol Sci 21(8):1759\u20131767","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"6616_CR28","doi-asserted-by":"publisher","first-page":"7963","DOI":"10.3892\/ol.2018.8341","volume":"15","author":"LP Wang","year":"2018","unstructured":"Wang LP et al (2018) HOTAIR contributes to the growth of liver cancer via targeting miR-217. Oncol Lett 15(5):7963\u20137972. https:\/\/doi.org\/10.3892\/ol.2018.8341","journal-title":"Oncol Lett"},{"issue":"32","key":"6616_CR29","doi-asserted-by":"publisher","first-page":"52475","DOI":"10.18632\/oncotarget.9655","volume":"7","author":"M Saiselet","year":"2016","unstructured":"Saiselet M et al (2016) miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers. Oncotarget 7(32):52475. https:\/\/doi.org\/10.18632\/oncotarget.9655","journal-title":"Oncotarget"},{"issue":"7","key":"6616_CR30","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.4103\/1673-5374.235073","volume":"13","author":"TB Sullivan","year":"2018","unstructured":"Sullivan TB et al (2018) Spatiotemporal microRNA profile in peripheral nerve regeneration: miR-138 targets vimentin and inhibits Schwann cell migration and proliferation. Neural Regen Res 13(7):1253. https:\/\/doi.org\/10.4103\/1673-5374.235073","journal-title":"Neural Regen Res"},{"key":"6616_CR31","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.2147\/OTT.S213210","volume":"12","author":"J Jin","year":"2019","unstructured":"Jin J et al (2019) miRNA-15a regulates the proliferation and apoptosis of papillary thyroid carcinoma via regulating AKT pathway. Onco Targets Ther 12:6217. https:\/\/doi.org\/10.2147\/OTT.S213210","journal-title":"Onco Targets Ther"},{"issue":"5","key":"6616_CR32","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1007\/s13277-015-4427-6","volume":"37","author":"J Long","year":"2016","unstructured":"Long J et al (2016) MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF. Tumour Biol 37(5):5821\u20135828. https:\/\/doi.org\/10.1007\/s13277-015-4427-6","journal-title":"Tumour Biol"},{"issue":"11","key":"6616_CR33","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s00018-019-03041-4","volume":"76","author":"A Soriano","year":"2019","unstructured":"Soriano A et al (2019) Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma. Cell Mol Life Sci 76(11):2231\u20132243. https:\/\/doi.org\/10.1007\/s00018-019-03041-4","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"6616_CR34","doi-asserted-by":"publisher","first-page":"E610","DOI":"10.1016\/j.ijrobp.2017.06.2069","volume":"99","author":"Y Men","year":"2017","unstructured":"Men Y et al (2017) MiR-323a-3p inhibits cell proliferation, migration, and invasion in esophageal squamous cell carcinoma via suppression FMR1. Int J Radiat Oncol Biol Phys 99(2):E610. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.06.2069","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"6616_CR35","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1158\/1078-0432","volume":"14","author":"TS Wong","year":"2008","unstructured":"Wong TS et al (2008) Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14(9):2588\u20132592. https:\/\/doi.org\/10.1158\/1078-0432","journal-title":"Clin Cancer Res"},{"issue":"4","key":"6616_CR36","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1159\/000366326","volume":"34","author":"Q Yuan","year":"2014","unstructured":"Yuan Q et al (2014) Upregulation of miR-184 enhances the malignant biological behavior of human glioma cell line A172 by targeting FIH-1. Cell Physiol Biochem 34(4):1125\u20131136. https:\/\/doi.org\/10.1159\/000366326","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"6616_CR37","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.3390\/cancers12102886","volume":"12","author":"T Kometani","year":"2020","unstructured":"Kometani T et al (2020) Increased expression of NPM1 suppresses p27Kip1 function in cancer cells. Cancers 12(10):2886. https:\/\/doi.org\/10.3390\/cancers12102886","journal-title":"Cancers"},{"issue":"1","key":"6616_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/stresses1010004","volume":"1","author":"M Mortoglou","year":"2021","unstructured":"Mortoglou M et al (2021) MicroRNA-regulated signaling pathways: potential biomarkers for pancreatic ductal adenocarcinoma. Stresses 1(1):30\u201347. https:\/\/doi.org\/10.3390\/stresses1010004","journal-title":"Stresses"},{"issue":"1","key":"6616_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4048\/jbc.2017.20.1.35","volume":"20","author":"SH Han","year":"2017","unstructured":"Han SH et al (2017) MicroRNA-222 expression as a predictive marker for tumor progression in hormone receptor-positive breast cancer. J Breast Cancer 20(1):35","journal-title":"J Breast Cancer"},{"issue":"1","key":"6616_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-017-0447-1","volume":"17","author":"H Gao","year":"2017","unstructured":"Gao H et al (2017) MicroRNA-222 influences migration and invasion through MIA3 in colorectal cancer. Cancer Cell Int 17(1):1\u201310. https:\/\/doi.org\/10.1186\/s12935-017-0447-1","journal-title":"Cancer Cell Int"},{"issue":"6","key":"6616_CR41","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.3892\/ol.2016.5250","volume":"12","author":"L Zhou","year":"2016","unstructured":"Zhou L et al (2016) Downregulation of miR-221\/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN. Oncol Lett 12(6):4419\u20134426. https:\/\/doi.org\/10.3892\/ol.2016.5250","journal-title":"Oncol Lett"},{"issue":"9","key":"6616_CR42","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1158\/0008-5472","volume":"79","author":"AK Srivastava","year":"2019","unstructured":"Srivastava AK et al (2019) Inhibition of miR-328\u20133p impairs cancer stem cell function and prevents metastasis in ovarian cancer. Cancer Res 79(9):2314\u20132326. https:\/\/doi.org\/10.1158\/0008-5472","journal-title":"Cancer Res"},{"issue":"2","key":"6616_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3892\/or_00000252","volume":"21","author":"MG Catalano","year":"2009","unstructured":"Catalano MG et al (2009) Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib. Oncol Rep 21(2):515\u2013521. https:\/\/doi.org\/10.3892\/or_00000252","journal-title":"Oncol Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06616-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06616-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06616-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T03:27:39Z","timestamp":1629343659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06616-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["6616"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06616-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-548056\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"31 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors agree to publish the data of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}